Context:

A TikTok influencer, Shayla Talei, who has complex regional pain syndrome and gastroparesis, clarifies that her stomach condition is not caused by GLP-1 weight-loss drugs and asserts she has never used them. She explains that her weight loss stems from the underlying disorder and describes severe gastroparesis symptoms that progressed to requiring total parenteral nutrition as a last resort. The piece notes online theories circulating about GLP-1 use and emphasizes her ongoing struggle, medical journey, and reliance on social media to raise awareness and maintain engagement with her community. The timeframe spans before and after July 2025, highlighting pivotal health declines, treatment steps, and the current emphasis on support networks and transparency.

Dive Deeper:

• Shayla Talei, a 31-year-old influencer, has been diagnosed with complex regional pain syndrome (CRPS) and gastroparesis, or stomach paralysis, which have led to significant health challenges and weight loss. She stresses that her condition emerged from medical issues rather than self-inflicted actions.

• She lost more than 100 pounds over eight months and sometimes could only manage three bites of food in a day, with symptoms including extreme bloating, nausea, vomiting, and chest-like pain when drinking water.

• Doctors attempted tube feeding before Talei required total parenteral nutrition (TPN) in July 2025, a central-vein nutrition method described as high-risk but necessary to deliver nutrients directly to the bloodstream.

• Talei denies ever using GLP-1 receptor agonists and counters online theories by reiterating that no weight-loss medication caused her condition, citing a May 2024 Cleveland Clinic study cited by commenters as the basis for GLP-1 concerns.

• She has publicly discussed the emotional toll and the role of social media in maintaining her career after closing her salon due to escalating health issues, noting that online support has been crucial for her and her two children.

• In recent content, Talei has explained practical aspects of living with her condition, such as showering with a central line, and she emphasizes gratitude for the community that has supported her through a difficult journey.

• The narrative also situates Talei within a broader conversation about Ozempic/GLP-1 weight-loss discourse, highlighting ongoing debates about the causes of gastroparesis and the pressures influencers face from online speculation.